|
RPS15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.242710E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.275910E-02 |
| Normal-vs-Stage2 |
2.057400E-01 |
| Normal-vs-Stage3 |
4.817300E-04 |
| Normal-vs-Stage4 |
2.835600E-03 |
| Stage1-vs-Stage2 |
6.144800E-01 |
| Stage1-vs-Stage3 |
9.648400E-02 |
| Stage1-vs-Stage4 |
2.506600E-01 |
| Stage2-vs-Stage3 |
1.432980E-01 |
| Stage2-vs-Stage4 |
2.262200E-01 |
| Stage3-vs-Stage4 |
8.956200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.880900E-03 |
| Normal-vs-AfricanAmerican |
1.822040E-02 |
| Normal-vs-Asian |
2.672200E-02 |
| Caucasian-vs-AfricanAmerican |
6.604400E-01 |
| Caucasian-vs-Asian |
7.614400E-01 |
| AfricanAmerican-vs-Asian |
8.743800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.223400E-04 |
| Normal-vs-Female |
5.382600E-03 |
| Male-vs-Female |
7.571900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.181500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.774410E-02 |
| Normal-vs-Age(61-80Yrs) |
4.562100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.661920E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.776800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.741400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.692800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.431800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.623800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.075600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.075200E-01 |
| Classical-VS-Follicular |
5.741600E-01 |
| Classical-VS-Other |
1.511610E-01 |
| Classical-VS-Normal |
8.781600E-03 |
| Tall-VS-Follicular |
3.458200E-01 |
| Tall-VS-Other |
1.824160E-01 |
| Tall-VS-Normal |
1.143350E-01 |
| Follicular-VS-Other |
3.554800E-01 |
| Follicular-VS-Normal |
8.416800E-03 |
| Other-VS-Normal |
3.172200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.391700E-04 |
| Normal-vs-N1 |
5.984800E-04 |
| N0-vs-N1 |
2.676000E-01 |
|
|
